While somatic cancer panel tests are available to oncologists, many questions remain on how to best integrate them into clinical practice. Chief among the questions are: (1) when to incorporate genomic testing during the course of a patient s care to achieve maximum benefit; and (2) whether repeated testing can serve to track cancer evolution and refine treatment regimens. Addressing these questions ultimately depends on the clinician s ability to understand the genomic information provided by these tests and to efficiently extract and evaluate actionable results. The Maine Cancer Genomics Initiative (MCGI) aims to overcome these barriers. The MCGI Genomic Tumor Board meeting series functions as an educational opportunity for oncology clinicians with the objectives outlined above. The MCGI provides an opportunity to serve as a model for community genomic medicine.
- Provider:Hanley Center for Health Leadership and Education
- Activity Link: https://www.jax.org/clinical-genomics/maine-cancer-genomics-initiative/genomic-tumor-boards
- Start Date: 2025-01-03 06:00:00
- End Date: 2025-01-03 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 114.0 hours
- Commercial Support: No
- Activity Type: Regularly Scheduled Series
- CME Finder Type: In-House Seminar
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence
- Provider Ship: Jointly Provided
- Registration: Limited